Condition: PCOS(Insulin Resistant) · Sponsor: Mst.Sumyara Khatun
Women with polycystic ovary syndrome with HOMA-IR \>2.6 fulfilling inclusion and exclusion criteria will be randomly allocated into two groups:experimental group: A (Melatonin 3mg and Metformin 500mg) and control group: B (Metformin 500mg). Each group will be contained 30 selected patients. Group B:Tab. Metformin (500mg) once daily for 7days followed by twice daily for next 7 days followed by thrice daily for next 10 weeks. Outcome variables will be measured after three months, will be meticulously recorded for analysis and comparison.
This description comes directly from the study's public registry record.
Mst.Sumyara Khatun, MS · +8801746046581 · sumirmc09@gmail.com
Farzana Rahman, MBBS · +8801914229346 · farzana47arshi91@gmail.com
Always discuss trial participation with your own doctor first.
| Bangladesh Medical University | Dhaka, Shahbag, Bangladesh | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07307677